SHARE: Simple HAART With Abacavir, Reyataz, and Epivir
Phase 4
- Conditions
- HIV InfectionsLipodystrophy
- Registration Number
- NCT00426296
- Lead Sponsor
- Clinical Alliance for Research & Education - Infectious Diseases, LLC.
- Brief Summary
SHARE: Simple HAART with Abacavir, Reyataz, and Epivir
- Detailed Description
Open-label, multicenter study of ABC/3TC + ATV in subjects who have completed at least 24 weeks of treatment on ABC/3TC+ATV/RTV as their first line regimen and have plasma HIV-1 RNA \<50 copies/mL at entry
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Currently taking abacavir/lamivudine (Epzicom) in combination with atazanavir (Reyataz) boosted with ritonavir (Norvir) as first antiretroviral regimen
- Viral load <50 copies/ml
Exclusion Criteria
- Viral load >50 copies/ml
- Having taken more than one antiretroviral regimen
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Whitman-Walker Clinic
🇺🇸Washington, District of Columbia, United States